2014, Number 3
<< Back Next >>
Rev Cent Dermatol Pascua 2014; 23 (3)
Epidemiology of tinea incognito in the Dermatology Center «Dr. Ladislao de la Pascua»
Padilla-Desgarennes MC, Morales-Sánchez MA, Lazo-García EC
Language: Spanish
References: 18
Page: 85-89
PDF size: 234.41 Kb.
ABSTRACT
Introduction: Tinea incognito or atypical is a dermatophytic infection in which the treatment with steroids has modified its clinical characteristics. This infection tends to spread and can be confused clinically with other skin diseases, making difficult its diagnosis. There are few studies about its prevalence and incidence.
Objective: To determine the incidence and clinical aspects of tinea incognito in the Centro Dermatológico «Dr. Ladislao de la Pascua».
Material and methods: A cross-sectional study was performed in the micology laboratory from January 2011 to December 2013 to identify the patients with the diagnosis of tinea incognito.
Results: The incidence of tinea incognito was 3.8 per 100 cases of tinea per year, more than 50% had involvement of the face, trunk and groin. The tinea was more common in women with a median age of 39 years. The most frequently isolated fungus was Trichophyton rubrum. The clinical diagnoses were: annular granuloma (25%), nummular dermatitis (19%) and lupus erythematosus (13%), among others.
Conclusion. Tinea incognito has an incidence consistent with the data reported in previous studies.
REFERENCES
Ive A, Marks R. Tinea incognito. Brit Med J. 1968; 3: 149-152.
Marks R. Tinea incognito. Int J Dermatol. 1978; 17: 301-302.
Arenas R, Moreno-Coutiño G, Vera L, Welsh O. Tinea incognito. Clin Dermatol. 2010; 28 (2): 137-139.
Jacobs JA, Kolbach DN, Vermeulen AH, Smeets MH, Neuman HA. Tinea incognito due to Trichophyton rubrum after local steroid therapy. Clin Infect Dis. 2001; 33: E142-144.
Conde-Salazar L, Sandin S, Valks R, Casado I. Tiña incógnita en dermatología laboral. Dermatol Peru. 2004; 14: 36-39.
Rallis E, Koumantaki ME. Pimecrolimus induced tinea incognito masquerading as intertriginous psoriasis. Mycoses. 2008; 51: 71-73.
Siddaiah N, Erickson Q. Tacrolimus-induced tinea incognito. Cutis. 2004; 73: 237-238.
Atzori L, Pau M, Aste N, Aste N. Dermatophyte infections mimicking other skin diseases: a 154-person case survey of tinea atypica in the district of Cagliari (Italy). Int J Dermatol. 2012; 51 (4): 410-415.
Torres S, Ortiz M, Padilla C. Tiña incógnita, reporte de un caso. Rev Cent Dermatol Pascua. 2007; 16 (3): 170-172.
Georgieva L, Petrov H, Tchernev G, Semkova K, Atanasova A, Ivanova K et al. Tinea atypical: report of nine cases. Wen Med Wochenschr. 2013; 163: 549-555.
Young WP et al. Tinea incognito simulating herpes simplex virus infection. Ann Dermatol. 2014; 26 (2): 267-269.
Won-Jeong K et al. Tinea incognito in Korea and its risk factors: nine-year multicenter survey. J Korean Med Sci. 2013; 28: 145-151.
Tan Y, Lin L, Feng P, Lai W. Dermatophytosis caused by Trichophyton rubrum mimicking syphilid: a case report and review of literature. Mycoses. 2014; 57: 312-315.
Romano C et al. Tinea incognito in Italy: a 15-year survey. Mycoses. 2006; 49: 383-387.
Mapelli ET, Borghi E, Cerri A et al. Tinea corporis due to Trichophyton rubrum in a woman and Tinea capitis in her 15-day-old baby: molecular evidence of vertical transmission. Mycopathologia. 2012; 173: 135-138.
Morales C, Bermúdez L. Tiña incógnita diseminada que simula psoriasis pustulosa. Rev Iberoamericana de Micología. 2012; 29 (1): 47-48.
del Boz J, Crespo V, Rivas-Ruiz F, de Troya M. Tinea incognito in children: 54 cases. Mycoses. 2011; 54: 254-258.
Ansar A, Frashchian M, Nazeri H, Ghiasian SA. Clinico-epidemiological and mycological aspects of tinea incognito in Iran: a 16 year study. Med Mycol J. 2011; 52: 25-32.